Connect with us

Spread & Containment

Seen at CES: Nuralogix uses AI and a selfie to measure your heart rate, BP, body mass, skin age, stress level and more

A picture is worth 1,000 words, as the saying goes, and now a startup called Nuralogix is taking this idea to the next level: Soon, a selfie will be able…

Published

on

A picture is worth 1,000 words, as the saying goes, and now a startup called Nuralogix is taking this idea to the next level: Soon, a selfie will be able give you 1,000 diagnostics about the state of your health.

Anura, the company’s flagship health and wellness app, takes a 30-second selfie and uses the data from that to create a catalogue of readings about you. They include vital stats like heart rate and blood pressure; mental health-related diagnostics like stress and depression levels; details about your physical state like body mass index and skin age; your level of risk for things like hypertension, stroke and heart disease; and biomarkers like your blood sugar levels.

Some of these readings are more accurate than others and are being improved over time. Just today, to coincide with CES in Vegas — where I came across the company — Nuralogix announced that its contactless blood pressure measurements were becoming more accurate, specifically with accuracy corresponding to a standard deviation of error of less than 8 mmHg.

Anura’s growth is part of a bigger trend in the worlds of medicine and wellness. The COVID-19 pandemic gave the world a prime opportunity to use and develop more remote health services, normalizing what many had thought of as experimental or suboptimal.

That, coupled with a rising awareness that regular monitoring can be key to preventing health problems, has led to a number of apps and devices proliferating the market. Anura is by far not the only one out there, but it’s a notable example of how companies are playing out the equation of relying on low friction to yield big results. That in a way has been the holy grail of a lot of modern medicine — it’s one reason why so many wanted Theranos to be real.

So while some pandemic-era behaviors are not sticking as firmly as people thought they might (e-commerce has not completely replaced in-person shopping, for one) observers believe there is a big future in tele-health and companies like Nuralogix providing the means to implement it.

Grandview Research estimates that tele-health was an $83.5 billion market globally in 2022 and that this number will balloon to $101.2 billion in 2023, growing at CAGR of 24% to 2030 when it will be a $455.3 billion market.

The startup — which is based out of Toronto, Canada, and backed by the city’s Mars Innovation effort (a consortium of universities and research groups helping to spin out academic research) and others — uses a B2B business model and counts Japan’s NTT and Spanish insurance provider Sanitas among its customers. It’s also talking to automotive companies that see the potential of being able to use this to track, say, when a driver is getting tired and distracted or having a health crisis of some other kind.

Right now, the results that Anura comes up with are positioned as guidance — for “investigational” insights that complement other kinds of assessments. The company claims to be compliant with HIPAA, GDPR and other data protection regulations as part of its wider security policy, and it’s currently going trough the process of FDA approval so that its customers can use the results in a more proactive manner.

It also has a Lite version of the application (on iOS and Android) where individuals can get some — but not all — of these diagnostics.

The Lite version is worth looking at not just as a way for the company to publicize itself but how it gathers data.

Nuralogix built Anura on the back of an AI that was trained on data from some 35,000 of different users. A typical 30-second video image of a user’s face is analyzed to see how blood moves around it. “Human skin is translucent,” the company notes. “Light and its respective wavelengths are reflected at different layers below the skin and can be used to reveal blood flow information in the human face.”

Ingrid testing out the app at CES. Image Credits; Ingrid Lunden

That in turn is matched up with different diagnostics from those people using traditional measuring tools and uploaded to the company’s “DeepAffex” Affective AI engine. Then users of the Anura app are essentially “read” based on what the AI has been trained to see: blood moving in one direction or another, or a person’s skin color, can say at lot about how the person is doing physically and mentally.

DeepAffex is potentially being used for more than just tele-health diagnostics. Previous to its pivot to health, the company’s AI technology and using this technique of “transdermal optical imaging” (shortened to TOI by the company) to “read” faces, was being applied to reading users’ emotions. One potential application of that was using the tech to augment or even replace traditional lie detector tests, which are regularly used by police and others to determine whether a person is representing things truthfully but have been proven to be flawed.

There are also horizons that extend into hardware. The current version of Anura is based on an app that you access via smartphones or tablets but longer term the company might also work on their own scanning devices to add in other kinds of facial scanning and other tools such as infrared to pick up even more information and produce more diagnostics. (One area for example that’s not currently touched is blood oxygen, an area that the company definitely wants to tackle.)

I tried out the full version of the Anura app this week in Las Vegas and have to say it’s a pretty compelling experience and indeed is low-friction enough to likely catch on with a lot of people. (As a measure of that, the company’s demo had a permanent queue of people waiting to try it out.)

Read more about CES 2023 on TechCrunch

Seen at CES: Nuralogix uses AI and a selfie to measure your heart rate, BP, body mass, skin age, stress level and more by Ingrid Lunden originally published on TechCrunch

Read More

Continue Reading

Government

New York Supreme Court Upholds Ban On COVID Vaccine Mandate For Health Workers

New York Supreme Court Upholds Ban On COVID Vaccine Mandate For Health Workers

Authored by Benjamin Kew via The Epoch Times (emphasis ours),

New…

Published

on

New York Supreme Court Upholds Ban On COVID Vaccine Mandate For Health Workers

Authored by Benjamin Kew via The Epoch Times (emphasis ours),

New York's Supreme Court has upheld its previous ruling invalidating the COVID-19 vaccine mandate for health care workers, a decision that will have ramifications on the power of the state's executive.

A health care worker prepares a dose Pfizer/BioNTEch COVID-19 vaccine at The Michener Institute in Toronto on Dec. 14, 2020. (Carlos Osorio/POOL/AFP via Getty Images)

The ruling came from the Supreme Court's Appellate Division, Fourth Department, which dismissed the state's appeal to have the mandate reinstated.

"4th Dept dismissed state’s appeal as moot, and declined to vacate lower court win," attorney Sujata Gibson wrote on X, formerly known as Twitter.

"The mandate is over and declared unconstitutional," she continued. "[Thank you] [Children's Health Defense], [Robert F. Kennedy Jr.], and [Medical Professionals For Informed Consent], and everyone who helped in this fight.

"Doesn’t make up for the harm [New York] Inflicted, but will help protect us from more."

The health care worker vaccine mandate was first implemented in September 2021, resulting in the departure or termination of about 34,000 medical professionals from their positions.

That mandate was originally struck down by the state's Supreme Court in January, although the state's executive branch chose to appeal the decision.

In his opinion in Medical Professionals for Informed Consent vs. Bassett, Justice Gerard Neri wrote that the state's Department of Health was "clearly prohibited from mandating any vaccination outside of those specifically authorized by the legislature" and that it had "blatantly violated the boundaries of its authority as set forth by the legislature.”

Justice Neri added that the mandate was “arbitrary and capricious” given that the COVID-19 vaccines failed to prevent transmission of the virus, meaning the policy had no rational basis.

New York Gov. Kathy Hochul, a Democrat, had previously explained her opposition to rehiring health care workers who lost their jobs as a result of the vaccine, saying that this was "not the right answer."

“I think everybody who goes into a health care facility or a nursing home should have the assurance and their family member should know that we have taken all steps to protect the public health," she said at the time. "And that includes making sure those who come in contact with them at their time of most vulnerability, when they are sick or elderly, will not pass on the virus."

In April, the state agreed to unilaterally drop the mandate of its own accord, although it still contested the decision for the sake of maintaining executive authority.

"Due to the changing landscape of the COVID-19 pandemic and evolving vaccine recommendations, the New York State Department of Health has begun the process of repealing the COVID-19 vaccine requirement for workers at regulated health care facilities," the state health department stated.

Last October, the New York Supreme Court also struck down a mandate enforced specifically by New York City on all public employees, with Justice Ralph Porzio arguing there was no evidence to "support the rationality of keeping a vaccination mandate for public employees, while vacating the mandate for private sector employees or creating a carveout for certain professions, like athletes, artists, and performers."

In January 2022, the U.S. Supreme Court similarly blocked an attempt by President Joe Biden to enforce a mandate on large private companies that their employees either get the vaccine or face regular testing. However, it did allow the mandate to continue in medical facilities that took funding from Medicare and Medicaid.

"Although Congress has indisputably given OSHA the power to regulate occupational dangers, it has not given that agency the power to regulate public health more broadly,” the court wrote in its unsigned opinion. "Requiring the vaccination of 84 million Americans, selected simply because they work for employers with more than 100 employees, certainly falls in the latter category."

Margaret Florini, a spokesperson for Medical Professionals for Informed Consent, told The Defender that the latest decision was a "historic" win that would help prevent such abuses of power in the future.

"I think we will see many new lawsuits come about because of this historic win," Ms. Florini said. "There is still plenty of work to be done. We lost so much, not just money but relationships, marriages, friends, and homes. We cannot forget what was done to us, and we must continue to shed light on it and make impactful changes that will truly prevent this from happening again."

Tyler Durden Mon, 10/16/2023 - 21:15

Read More

Continue Reading

International

Memory in action: what the UK’s official COVID commemoration should look like

Memorialising a pandemic that is still underway is a challenge. Official commemoration needs to be about remembrance and preparedness.

Published

on

By

Whether an actual bereavement or a loss of experience, everyone has lost something to COVID. From early on in the pandemic, grassroots memorials sought to acknowledge this collective experience, including the national COVID memorial wall in London and the annual national day of reflection organised by the Marie Curie charity.

In September 2023, the UK Commission on COVID Commemoration released its final report on how a more official reckoning with the pandemic’s legacy should be shaped. It outlines ten recommendations.

The pandemic has affected people in vastly different ways. How governments, institutions and the wider public have responded has varied enormously, too. It is also still ongoing, which complicates things further.

New variants of the virus are on the rise. And nearly two million people in the UK alone continue to suffer with long COVID.

As immunologist Sheena Cruickshank put it recently, “it may feel like we should all be done with COVID-19, but sadly COVID-19 is not done with us”.

My research into memorial culture and modernism shows how the lack of a clear or coherent narrative for an event like a pandemic makes commemorating it that much harder. The official and cultural memory of the 1918 flu pandemic was subsumed into that of the first world war – and it remained largely unremembered, until COVID brought it back to public attention.

Nurses began erecting memorials early on in the first world war. Wellcome Collection Images, CC BY-NC-ND

Remembrance and preparedness

From October to December 2022, the UK Commission on Covid Commemoration held a six-week period of public consultation. It conducted surveys, garnering 5,000 responses. It also met with affected groups, including bereaved families and long-COVID sufferers, as well as groups that are sceptical about the illness and lockdown strategies.

The report is, to my mind, admirably well considered, sensitive to the difficulties of the task. It firmly establishes why memorialising all deaths that have occurred during the pandemic – COVID-related or otherwise – is necessary. This chimes with previous research that has found that COVID-related grief is particularly difficult and that public commemoration is necessary for social cohesion.

The 11 members of the commission suggest a range of commemorations, which will now be considered for implementation by the British government. These include an annual day of reflection on the first Sunday in March, a new symbol to represent the pandemic, the establishment of a commemoration trust to organise and promote these initiatives, along with a commemoration website and an online book of remembrance.

The commissioners suggest creating ten green spaces across the country, each boasting a sculpture created by local artists. They recommend preserving those grassroots initiatives already in place, including the national COVID memorial wall.

Finally, they propose various educational initiatives. These include teaching the history of the pandemic in schools and college and collating oral histories from a wide range of groups, to, as the report puts it, “serve as a historical record of this period of our time and as an educational tool for future generations”. A postdoctoral fellowship programme is suggested, too, to enable future researchers to work with policy makers on national preparedness for natural hazards.

Most of these recommendations are fairly standard commemorative gestures. The decision to create disparate pockets of remembrance across the UK rather than one large-scale memorial is expected, as there is no consensus or agreed-upon version of the pandemic.

The choice of green spaces is usefully open-ended in terms of meaning. The memorial sculptures destined for each will, doubtless, be similarly open-ended, in keeping with the minimalist, abstract and predominantly secular tendencies in modern contemporary memorials in the UK.

The report also proposes council funding for local commemorative spaces in existing parks or green spaces, not unlike the many community-led first world war memorials.

The COVID symbol the commission suggests is a zinnia flower. Associated with remembrance, this floral design has similarities to the poppy which has long symbolised the first world war.

Large-scale commemorative gestures have already been seen in other nations. Most notably, Joe Biden’s first act as US president was, during his inaugural address, to lead a moment of silence to remember the then 400,000 Americans lost to the pandemic.

By contrast, the UK public has felt left down by its government’s response. The news, that former prime minister Boris Johnson reportedly said, in autumn 2020, that he would rather see “bodies pile high” than impose a third lockdown on the UK, has left a bitter taste.

Johnson’s subsequent clandestine evening trip, in April 2021, to the COVID memorial wall, as well as public scandals such as Partygate, have further angered the public. Bereaved family groups such as COVID-19 Bereaved Families for Justice are understandably anxious to see that their loved ones are remembered officially as names and not as numbers.

The commission is eager to distinguish itself from the contentious COVID-19 Inquiry. This report is a useful corrective to the inadequacies of the British government in commemorating the pandemic to date.

Some may wonder if it is too early to commemorate a pandemic that isn’t yet over. After 1914, nurses began to create memorials as soon as the first deaths happened. The British government established the Imperial War Museum in 1917, while the war was still ongoing. I have shown how necessary these commemorative gestures were. They ensured that the dead were not forgotten.

Whether the government will now do is yet to be seen. In its insistence both on remembrance and on preparedness – for the next pandemic that, experts agree, will happen – this report is a good first step.

Alice Kelly received a British Academy Rising Star Engagement Award from 2017-19 for a seminar series entitled "Cultures and Commemorations of War."

Read More

Continue Reading

Government

Only 2% Of Americans Have Received New COVID Vaccine: CDC

Only 2% Of Americans Have Received New COVID Vaccine: CDC

Authored by Jack Phillips via The Epoch Times,

About 2 percent of all Americans…

Published

on

Only 2% Of Americans Have Received New COVID Vaccine: CDC

Authored by Jack Phillips via The Epoch Times,

About 2 percent of all Americans have received the updated COVID-19 booster shot after it was authorized and recommended by federal health officials several weeks ago, according to updated data provided by the Department of Health and Human Services (HHS).

More than 7 million Americans have taken the updated shot, which is authorized for people aged 6 months and older, said an HHS spokesman. That's approximately 2 percent of all Americans.

“COVID-19 vaccine distribution, which has shifted to the private market, is a lot different than it was last year when the government was distributing them," said a spokesperson for HHS about the vaccination data. It added that the agency is "directly with manufacturers and distributors to ensure that the vaccines are getting to" various locations.

The statement added that 91 percent of Americans aged 12 years and older "can access the vaccine within 5 miles of where they live," adding that 14 million updated boosters for COVID-19 have been shipped to pharmacies and other locations. The vaccine was approved about a month ago by the Food and Drug Administration (FDA) before it was recommended by the U.S. Centers for Disease Control and Prevention (CDC) shortly thereafter.

It came as some people reported that it's difficult to find doses of the new vaccines at local pharmacies and doctors. Jen Kates, a senior vice president at the Kaiser Family Foundation, said on X in September that her vaccine appointment was canceled due to a lack of supply.

The 7 million figure is up since Oct. 6 when Dr. Mandy Cohen, director of the CDC, told reporters that 4 million had received the new vaccines.

The HHS said Thursday that the latest updated vaccinate rate is about the same as the initial bivalent booster shot when it was rolled out in 2022. However, demand for the 2022 booster vaccine was similarly low, according to CDC data.

Data has shown that about 17 percent of the U.S. population got that previous updated shot, or around 56.5 million people.

The updated vaccines were meant to target the COVID-19 XBB.1.5 variant, which was spreading across the United States when companies like Moderna and Pfizer came up with the new version.

Observational data for the bivalent vaccines, or the previous versions, found weak initial effectiveness that quickly waned.

CDC officials made unsupported claims during the briefing, part of a trend for the agency. “These vaccines will prevent severe disease for COVID-19,” Dr. Demetre Daskalakis, director of the CDC’s National Center for Immunization and Respiratory Disease, told reporters. There’s no evidence that’s true.

The only clinical study data for the new shots is from a study Moderna ran that included injecting 50 humans with the company’s updated formation. The result was a higher level of neutralizing antibodies. Officials believe antibodies protect against COVID-19.

Moderna did not provide any clinical efficacy estimates for infection, severe disease, or death. Pfizer said it was running a trial but has not reported any results.

Novavax’s vaccine was authorized later without any new trial data, as CDC officials have said they recommend that shot. Unlike the Moderna and Pfizer vaccines, Novavax doesn't use mRNA technology and is protein-based.

Hospitalizations Down

Despite the recent push for the latest vaccines, data provided by the CDC shows that hospitalizations for COVID-19 have been down for about three consecutive weeks.

For the ending Sept. 30, the hospitalization rate is down by 6 percent, while emergency department visits are down by 14.5 percent and COVID-19 cases are down 1.2 percent, the figures show. Deaths are up 3.8 percent, although health officials have previously said that deaths generally lag behind hospitalizations and case numbers.

In July, COVID-19 hospitalizations had been increasing for several consecutive weeks. CDC historical data suggest that deaths have been relatively low compared with previous years.

But with the release of the Sept. 30 data, hospitalizations have dropped for multiple consecutive weeks.

Dr. Shira Doron, chief infection control officer for Tufts Medicine, told ABC News that that the recent “upswing is not a surge; it’s not even a wave.”

The doctor added: “What we’re seeing is a very gradual and small upward trajectory of cases and hospitalizations, without deaths really going along, which is great news.”

The CDC on Oct. 6 released a report that attempted to push older Americans to get the newest vaccines by saying that COVID-19 is still a "public health threat," namely for people aged 65 and older. The majority of hospitalizations, it said, is occurring among that older demographic, according to the paper.

In the meantime, a handful of hospitals in California, New York state, Massachusetts, and New Jersey have re-implemented mandatory masking—at least for staff.

Several Northern California counties issued a mask mandate for all health care staff starting next month and ending in late April 2024. They include Contra Costa, Sonoma, Alameda, and San Mateo counties. Officials in the Southern California county of San Luis Obispo also issued a vaccine-or-mask mandate earlier this month.

Tyler Durden Mon, 10/16/2023 - 12:20

Read More

Continue Reading

Trending